ZOLMITRIPTAN
Generic: ZOLMITRIPTAN
Alembic Pharmaceuticals Inc.Manufacturer
ORALRoute
ZOLMITRIPTANActive Substance
2016-12-01Original Approval
ZOLMITRIPTAN is FDA application ANDA205074, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HEADACHE
459 reports
2
OFF LABEL USE
374 reports
3
DRUG INEFFECTIVE
340 reports
4
DRUG INTOLERANCE
302 reports
5
NAUSEA
267 reports
6
MIGRAINE
236 reports
7
HYPERSENSITIVITY
235 reports
8
ANGIOEDEMA
221 reports
9
SWELLING FACE
218 reports
10
SWOLLEN TONGUE
216 reports